Restart Life Sciences Corp.
NMLSF
$0.05
-$0.01-15.84%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -386.61% | 58.90% | -112,900.00% | -145.47% | -122.21% |
| Total Depreciation and Amortization | 2,066.67% | 866.67% | -25.00% | -25.00% | -25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,315.19% | -78.87% | 15,963.64% | 107.71% | -- |
| Change in Net Operating Assets | -348.29% | 790.77% | -3,840.00% | -21.81% | -4.95% |
| Cash from Operations | -530.48% | 67.48% | -2,782.72% | -1,636.36% | -690.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 1,566.67% | -- | -- |
| Total Debt Repaid | -- | 93.98% | -- | -- | -- |
| Issuance of Common Stock | -- | -13.69% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 2.06% | 12,221.50% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -534.58% | -303.53% | 41,626.92% | -1,636.36% | -690.14% |